Stocks
Eli Lilly and Company (LLY) ROE US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 177.9% | 109.8% | 62.2% | 58.6% | 48.6% | 54.1% | ||
| Changes by years, y/y, % | +145pp | -68pp | -48pp | -4pp | -10pp | +8.1% | |||
Eli Lilly and Company. ROE, %
Eli Lilly and Company. ROE, changes, pp
Eli Lilly and Company (LLY) ROE US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| ROE, % | ? | 58.7% | 44.5% | 48.6% | 47.9% | 54.1% | 54.1% | |
| Changes by years, y/y, % | -8pp | -15pp | -10pp | -3pp | -5pp | |||
| Changes by quarters, q/q, % | +8pp | -14pp | +4pp | -1pp | +6pp | |||
